This novel mechanism not only adds a pro-apoptotic immunological dimension to NGF/TrkA interaction in neuroblasts but also provides a novel potential pro-apoptotic therapeutic strategy for the use of NGF and TRAIL in TrkA-expressing NB. The gene discussed is NGF; the disease is neuroblastoma.